ACIU
Price
$2.07
Change
-$0.00 (-0.00%)
Updated
Jul 18 closing price
Capitalization
208.24M
16 days until earnings call
NAGE
Price
$10.18
Change
+$0.02 (+0.20%)
Updated
Jul 21, 10:33 AM (EDT)
Capitalization
800.69M
16 days until earnings call
Interact to see
Advertisement

ACIU vs NAGE

Header iconACIU vs NAGE Comparison
Open Charts ACIU vs NAGEBanner chart's image
AC Immune SA
Price$2.07
Change-$0.00 (-0.00%)
Volume$122.89K
Capitalization208.24M
Niagen Bioscience
Price$10.18
Change+$0.02 (+0.20%)
Volume$350
Capitalization800.69M
ACIU vs NAGE Comparison Chart in %
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. NAGE commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Hold and NAGE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ACIU: $2.07 vs. NAGE: $10.16)
Brand notoriety: ACIU and NAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 116% vs. NAGE: 121%
Market capitalization -- ACIU: $208.24M vs. NAGE: $800.69M
ACIU [@Biotechnology] is valued at $208.24M. NAGE’s [@Biotechnology] market capitalization is $800.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileNAGE’s FA Score has 1 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • NAGE’s FA Score: 1 green, 4 red.
According to our system of comparison, NAGE is a better buy in the long-term than ACIU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 3 TA indicator(s) are bullish while NAGE’s TA Score has 5 bullish TA indicator(s).

  • ACIU’s TA Score: 3 bullish, 3 bearish.
  • NAGE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ACIU and NAGE are a good buy in the short-term.

Price Growth

ACIU (@Biotechnology) experienced а -1.90% price change this week, while NAGE (@Biotechnology) price change was -10.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

ACIU is expected to report earnings on Aug 06, 2025.

NAGE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAGE($801M) has a higher market cap than ACIU($208M). NAGE YTD gains are higher at: 91.612 vs. ACIU (-23.333). NAGE has higher annual earnings (EBITDA): 14.7M vs. ACIU (-49.71M). ACIU has more cash in the bank: 146M vs. NAGE (55.5M). NAGE has less debt than ACIU: NAGE (3.52M) vs ACIU (5.18M). NAGE has higher revenues than ACIU: NAGE (108M) vs ACIU (28.3M).
ACIUNAGEACIU / NAGE
Capitalization208M801M26%
EBITDA-49.71M14.7M-338%
Gain YTD-23.33391.612-25%
P/E RatioN/A56.47-
Revenue28.3M108M26%
Total Cash146M55.5M263%
Total Debt5.18M3.52M147%
FUNDAMENTALS RATINGS
ACIU vs NAGE: Fundamental Ratings
ACIU
NAGE
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
9729
PRICE GROWTH RATING
1..100
5337
P/E GROWTH RATING
1..100
8599
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACIU's Valuation (49) in the Pharmaceuticals Major industry is somewhat better than the same rating for NAGE (82) in the Chemicals Specialty industry. This means that ACIU’s stock grew somewhat faster than NAGE’s over the last 12 months.

NAGE's Profit vs Risk Rating (73) in the Chemicals Specialty industry is in the same range as ACIU (100) in the Pharmaceuticals Major industry. This means that NAGE’s stock grew similarly to ACIU’s over the last 12 months.

NAGE's SMR Rating (29) in the Chemicals Specialty industry is significantly better than the same rating for ACIU (97) in the Pharmaceuticals Major industry. This means that NAGE’s stock grew significantly faster than ACIU’s over the last 12 months.

NAGE's Price Growth Rating (37) in the Chemicals Specialty industry is in the same range as ACIU (53) in the Pharmaceuticals Major industry. This means that NAGE’s stock grew similarly to ACIU’s over the last 12 months.

ACIU's P/E Growth Rating (85) in the Pharmaceuticals Major industry is in the same range as NAGE (99) in the Chemicals Specialty industry. This means that ACIU’s stock grew similarly to NAGE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUNAGE
RSI
ODDS (%)
Bearish Trend 6 days ago
86%
Bullish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
73%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 22 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
78%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEUDX8.830.01
+0.11%
American Century Equity Income R6
LGOAX42.00-0.06
-0.14%
Patient Opportunity A
HNRGX28.16-0.05
-0.18%
Hennessy Energy Transition Investor
DPLGX28.26-0.08
-0.28%
Jackson Square Large-Cap Growth IS
GWETX31.69-0.23
-0.72%
AMG GW&K Small Cap Core N

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with RGNX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
N/A
RGNX - ACIU
44%
Loosely correlated
-6.10%
ARCT - ACIU
44%
Loosely correlated
-0.30%
ABOS - ACIU
43%
Loosely correlated
+1.35%
RXRX - ACIU
41%
Loosely correlated
+5.80%
CRBU - ACIU
41%
Loosely correlated
+12.02%
More

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with MDGL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
-1.83%
MDGL - NAGE
44%
Loosely correlated
-4.19%
FHTX - NAGE
34%
Loosely correlated
+0.49%
VIR - NAGE
33%
Poorly correlated
-1.46%
CRSP - NAGE
33%
Poorly correlated
+18.22%
ACIU - NAGE
33%
Poorly correlated
N/A
More